Clinical Trials Logo

Enterocolitis, Pseudomembranous clinical trials

View clinical trials related to Enterocolitis, Pseudomembranous.

Filter by:

NCT ID: NCT00304356 Completed - Clinical trials for Pseudomembranous Colitis

Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection

Start date: January 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is for compassionate use of nitazoxanide in the treatment of diarrheal disease due to Clostridium difficile infection when the patient has failed previous treatment with metronidazole or vancomycin.

NCT ID: NCT00196794 Completed - Diarrhea Clinical Trials

A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea

Start date: April 2005
Phase: Phase 3
Study type: Interventional

Approximately 520 patients will be entered into this study taking place throughout Australia and Europe. This study aims to determine if an investigational drug is safe and effective for treating symptoms of C. difficile-associated diarrhea (CDAD) and lowering the risk of repeat episodes of CDAD. The investigational drug will be evaluated in comparison to current standard antibiotic treatment, so all patients will receive active medication. All study related care is provided including doctor visits, physical exams, laboratory tests, and study medication. The total length of participation is approximately 6 weeks.

NCT ID: NCT00182429 Completed - Clinical trials for Antibiotic-Associated Diarrhea

Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

Start date: February 2004
Phase: Phase 3
Study type: Interventional

What is the difference between the use of one drug (Oral Metronidazole) versus the use of this same drug combined with another drug (Rifampin) in treatment of bacteria and infection-associated diarrhea in patients? This infection is an important cause of morbidity and mortality in both the community and hospitals, and the leading cause of hospital and chronic facility-acquired diarrhea. Research is important for the treatment of this infection. Patient care with use of two medication treatment regimens will be studied.

NCT ID: NCT00106509 Completed - Clinical trials for Pseudomembranous Colitis

A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

Start date: March 2005
Phase: Phase 3
Study type: Interventional

Approximately 520 patients will be entered into this study taking place throughout the US and Canada. This study aims to determine if an investigational drug is safe and effective for treating symptoms of C. difficile-associated diarrhea (CDAD) and lowering the risk of repeat episodes of CDAD. The investigational drug will be evaluated in comparison to current standard antibiotic treatment, so all patients will receive active medication. All study related care is provided including doctor visits, physical exams, laboratory tests and study medication. Total length of participation is approximately 6 weeks.

NCT ID: NCT00034294 Completed - Clinical trials for Antibiotic-associated Diarrhea

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Start date: February 2002
Phase: Phase 2
Study type: Interventional

Approximately 300 patients will be entered into this study taking place throughout the United States, Canada and the United Kingdom. This study aims to determine if an investigational drug is safe and effective for treating the symptoms of C. difficile-associated diarrhea and lowering the risk of repeat episodes of diarrhea. The investigational drug will be evaluated in comparison to current standard antibiotic treatment, so all patients will receive active medication. All study-related care is provided including doctor visits, physical exams, laboratory tests and study medication. Total length of participation is approximately 10 weeks.